Difficulty: Medium
Average Score: 75%
Practice
A patient is administered a granulocyte colony-stimulating factor (G-CSF). What is the expected outcome of a G-CSF?
Correct answer
B
Rationale
Granulocyte colony-stimulating factors like filgrastim enhance neutrophil production, reducing neutropenia's severity and duration, a common chemotherapy side effect, thereby lowering infection risk. Red blood cell counts and fatigue relate to erythropoiesis, not G-CSF's myeloid focus, while an arbitrary white cell count like 20,000 isn't the goal neutrophil recovery is. By bolstering innate immunity, it prevents bacterial infections, a critical outcome in immunocompromised states, reflecting its role in supporting patients through marrow-suppressing treatments without directly addressing anemia or energy levels.